Detalle Publicación

ARTÍCULO
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER plus ) node-negative breast cancer
Autores: Albanell, J.; González Martín, Antonio; Ruiz-Borrego, M.; Alba, E.; Garcia-Saenz, J. A.; Corominas, J. M.; Burgues, O.; Furio, V.; Rojo, A.; Palacios, J.; Bermejo, B.; Martínez-García, M.; Limon, M. L.; Munoz, A. S.; Martín, M.; Tusquets, I.; Rojo, F.; Colomer, R.; Faull, I.; Lluch, A.
Título de la revista: ANNALS OF ONCOLOGY
ISSN: 0923-7534
Volumen: 23
Número: 3
Páginas: 625-631
Fecha de publicación: 2012
Resumen:
Results from the first prospective European study are consistent with published experience and use of the RS as proposed in European clinical practice guidelines and provide evidence on how Oncotype DX and clinicopathological factors are complementary and patient selection may be improved.